Archive: Alzheimer’s disease
Aducanumab (AduhelmTM) – the first disease-modifying treatment for Alzheimer’s disease approved by the US Food and Drug Administration, 7 June 2021
Availability of Aduhelm remains unclear Coverage by Medicare and other third-party payers unknown More information to follow R. Scott Turner, PhD, MD, and the Memory Disorders Program On
Alz in the Fam: A Podcast Featuring Brigid Reynolds
Episode 9 of Alz In The Fam features Brigid Reynolds – neurology provider at Georgetown University’s Memory Disorders Program. All four Fair siblings sit down with Brigid, their first ever guest, to discuss their Mom’s journey with Alzheimer’s!
Study Researches Whether Nicotine Patch Can Help People With Memory Loss
The clinical trial is the largest and longest of its kind, enrolling up to 300 people in 23 states to test the theory.
Georgetown’s Alzheimer’s clinic marks 20 years, but hopes research can make it obsolete
Alison Starling with WJLA visits Carolyn Ward, Program Coordinator at the Georgetown University Memory Disorders Program.
The Presentation Slides from the 20th Anniversary Celebration
On Thursday, October 17th, 2019 the Georgetown University Memory Disorders Program hosted the 20th Anniversary Celebration commemorating twenty years of research and clinical care. Here you will find the information that was presented: The Journey of the Memory Disorders Program, Genetics and Alzheimer’s Disease, The Four Pillar Program to Preserving Brain Health, and Prevention Trial Registries. Thank you to all who supported this event and our program throughout the years.